
Minoxidil (5% w/v) + Finasteride (0.1% w/v)
Active composition
+1 more active ingredient
Minoxidil opens potassium channels in vascular smooth muscle, leading to vasodilation and reduced peripheral resistance.
Finasteride inhibits the enzyme 5-alpha-reductase, which converts testosterone into dihydrotestosterone (DHT), a hormone responsible for prostate growth and hair loss.
Medical applications
Kera-FM 5% Topical Solution is a dual-action formulation combining Minoxidil 5% w/v and Finasteride 0.1% w/v, designed for the treatment of androgenetic alopecia in both men and women. Minoxidil, a potent vasodilator, promotes hair regrowth by enhancing follicular blood flow and prolonging the anagen phase of the hair cycle, thereby stimulating dormant hair follicles. Finasteride, a selective 5-alpha-reductase inhibitor, reduces the conversion of testosterone to dihydrotestosterone (DHT), a key androgen responsible for follicular miniaturization and progressive hair loss. The topical delivery system of Kera-FM allows localized action with minimized systemic absorption, potentially reducing the risk of systemic side effects commonly associated with oral finasteride. This combination therapy offers a synergistic effect, addressing both the hormonal and vascular components of hair thinning. Kera-FM 5% Topical Solution is applied once or twice daily to the affected scalp areas, ensuring consistent exposure to active ingredients. Patients should use the product continuously for several months to observe visible improvement, with regular monitoring advised to assess efficacy and tolerability. Common adverse effects may include scalp irritation, itching, or dryness. Consultation with a healthcare professional is recommended prior to initiation, especially in individuals with hypersensitivity or contraindications to either component.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Kera-FM 5% Topical Solution is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
High Risk
Kera-FM 5% Topical Solution is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby. Not indicated for use in women.
Medical Advice
No interaction found/established
Exercise Caution
No interaction found/established
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Kera-FM 5% Topical Solution

Minoxidil (5% w/v) + Finasteride (0.1% w/v)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Minoxidil opens potassium channels in vascular smooth muscle, leading to vasodilation and reduced peripheral resistance.
Finasteride inhibits the enzyme 5-alpha-reductase, which converts testosterone into dihydrotestosterone (DHT), a hormone responsible for prostate growth and hair loss.
Medical applications
Kera-FM 5% Topical Solution is a dual-action formulation combining Minoxidil 5% w/v and Finasteride 0.1% w/v, designed for the treatment of androgenetic alopecia in both men and women. Minoxidil, a potent vasodilator, promotes hair regrowth by enhancing follicular blood flow and prolonging the anagen phase of the hair cycle, thereby stimulating dormant hair follicles. Finasteride, a selective 5-alpha-reductase inhibitor, reduces the conversion of testosterone to dihydrotestosterone (DHT), a key androgen responsible for follicular miniaturization and progressive hair loss. The topical delivery system of Kera-FM allows localized action with minimized systemic absorption, potentially reducing the risk of systemic side effects commonly associated with oral finasteride. This combination therapy offers a synergistic effect, addressing both the hormonal and vascular components of hair thinning. Kera-FM 5% Topical Solution is applied once or twice daily to the affected scalp areas, ensuring consistent exposure to active ingredients. Patients should use the product continuously for several months to observe visible improvement, with regular monitoring advised to assess efficacy and tolerability. Common adverse effects may include scalp irritation, itching, or dryness. Consultation with a healthcare professional is recommended prior to initiation, especially in individuals with hypersensitivity or contraindications to either component.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Kera-FM 5% Topical Solution is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
High Risk
Kera-FM 5% Topical Solution is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby. Not indicated for use in women.
Medical Advice
No interaction found/established
Exercise Caution
No interaction found/established
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Kera-FM 5% Topical Solution















